Medallion Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62K Sell
14
-329
-96% -$336K ﹤0.01% 869
2026
Q1
$315K Buy
343
+58
+20% +$58.8K 0.1% 182
2025
Q4
$306K Sell
285
-30
-10% -$28.7K 0.1% 185
2025
Q3
$240K Buy
315
+10
+3% +$7.44K 0.09% 206
2025
Q2
$237K Buy
305
+40
+15% +$31.1K 0.09% 208
2025
Q1
$213K Buy
265
+3
+1% +$2.5K 0.1% 194
2024
Q4
$202K Buy
+262
New +$217K 0.1% 189

Other funds holding LLY

Medallion Wealth Advisors's LLY Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Eli Lilly (LLY) stake by 96% in Q2 2026, selling an estimated $336K and leaving 14 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #869.

Medallion Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $315K in Q1 2026. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Medallion Wealth Advisors held 14 shares of Eli Lilly worth $4.62K as of Q2 2026.
  • Medallion Wealth Advisors sold 329 Eli Lilly shares in Q2 2026, an estimated $336K.
  • Eli Lilly made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #869 holding.
  • Medallion Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Eli Lilly position peaked at $315K in Q1 2026.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.